A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess if a therapy with oral and intravenous moxifloxacin is
as effective as a therapy with intravenous ceftriaxone + intravenous azithromycin followed by
oral amoxicilline/clavulanate and oral clarithromycin in the treatment of community-acquired
pneumonia.